Shunying Yu

Prof. Shunying Yu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2019 in Genome Biology
Verified
Journal Article
Open access
PDF file
XLXiao Liu
Xiao Liu
WSWeichen Song
Weichen Song
BWBrandon Y. Wong
Brandon Y. Wong
TZTing Zhang
Ting Zhang
SYShunying Yu
Shunying Yu
Xianting DingXianting Ding
Xianting Ding
Background: With the expanding applications of mass cytometry in medical research, a wide variety of clustering methods, both semi-supervised and unsupervised, have been developed for data analysis. Selecting the optimal clustering method can accelerate the identification of meaningful cell populations.Result: To address this issue, we compared three classes of performance measures, “precision” as external evaluation, “coherence” as internal evaluation, and stability, of nine methods based on six independent benchmark datasets. Seven unsupervised methods (Accense, Xshift, PhenoGraph, FlowSOM, flowMeans, DEPECHE, and kmeans) and two semi-supervised methods (Automated Cell-type Discovery and Classification and linear discriminant analysis (LDA)) are tested on six mass cytometry datasets. We compute and compare all defined performance measures against random subsampling, varying sample sizes, and the number of clusters for each method. LDA reproduces the manual labels most precisely but does not rank top in internal evaluation. PhenoGraph and FlowSOM perform better than other unsupervised tools in precision, coherence, and stability. PhenoGraph and Xshift are more robust when detecting refined sub-clusters, whereas DEPECHE and FlowSOM tend to group similar clusters into meta-clusters. The performances of PhenoGraph, Xshift, and flowMeans are impacted by increased sample size, but FlowSOM is relatively stable as sample size increases.Conclusion: All the evaluations including precision, coherence, stability, and clustering resolution should be taken into synthetic consideration when choosing an appropriate tool for cytometry data analysis. Thus, we provide decision guidelines based on these characteristics for the general reader to more easily choose the most suitable clustering tools.

3 August 2017 in Molecular Autism
Verified
Journal Article
Open access
PDF file
ZWZhu Wen
Zhu Wen
TCTian-Lin Cheng
Tian-Lin Cheng
GLGai-Zhi Li
Gai-Zhi Li
SSShi-Bang Sun
Shi-Bang Sun
SYShunying Yu
Shunying Yu
ZQZilong Qiu
Zilong Qiu
Methyl-CpG-binding protein-2 (MeCP2) is a critical regulator for neural development. Either loss- or gain-of-function leads to severe neurodevelopmental disorders, such as Rett syndrome (RTT) and autism spectrum disorder (ASD). We set out to screen for MECP2 mutations in patients of ASD and determine whether these autism-related mutations may compromise the proper function of MeCP2. Whole-exome sequencing was performed to screen MECP2 and other ASD candidate genes for 120 patients diagnosed with ASD. The parents of patients who were identified with MECP2 mutation were selected for further Sanger sequencing. Each patient accomplished the case report form including general information and clinical scales applied to assess their clinical features. Mouse cortical neurons and HEK-293 cells were cultured and transfected with MeCP2 wild-type (WT) or mutant to examine the function of autism-associated MeCP2 mutants. HEK-293 cells were used to examine the expression of MeCP2 mutant constructs with Western blot. Mouse cortical neurons were used to analyze neurites and axon outgrowth by immunofluorescence experiments. We identified three missense mutations of MECP2 from three autism patients by whole-exome sequencing: p.P152L (c.455C>T), p.P376S (c.1162C>T), and p.R294X (c.880C>T). Among these mutations, p.P152L and p.R294X were de novo mutations, whereas p.P376S was inherited maternally. The diagnosis of RTT was excluded in all three autism patients. Abnormalities of dendritic and axonal growth were found after autism-related MeCP2 mutants were expressed in mouse cortical neurons; suggesting that autism-related MECP2 mutations impair the proper development of neurons. Our study identified genetic mutations of the MECP2 gene in autism patients, which were previously considered to be associated primarily with RTT. This finding suggests that loss-of-function mutations of MECP2 may also lead to autism spectrum disorders.

25 October 2012 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Verified
Journal Article
Closed access
PDF file
AYAihua Yuan
Aihua Yuan
ZYZhenghui Yi
Zhenghui Yi
QWQiang Wang
Qiang Wang
JSJinhua Sun
Jinhua Sun
ZLZhiqiang Li
Zhiqiang Li
SYShunying Yu
Shunying Yu

12 October 2010 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
CZChen Zhang
Chen Zhang
ZLZezhi Li
Zezhi Li
YSYang Shao
Yang Shao
BXBin Xie
Bin Xie
YDYasong Du
Yasong Du
SYShunying Yu
Shunying Yu

23 April 2016 in Journal of Neuroimmune Pharmacology
Verified
Journal Article
Closed access
PDF file
YZYan Zhao
Yan Zhao
KZKai Zhang
Kai Zhang
HJHaifeng Jiang
Haifeng Jiang
JDJiang Du
Jiang Du
ZNZong Na
Zong Na
MZMin Zhao
Min Zhao

1 April 2014 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
CZChen Zhang
Chen Zhang
JCJun Cai
Jun Cai
JZJiangtao Zhang
Jiangtao Zhang
ZLZezhi Li
Zezhi Li
ZGZhongwei Guo
Zhongwei Guo
YFYiru Fang
Yiru Fang